1. Home
  2. TRIB vs PCLA Comparison

TRIB vs PCLA Comparison

Compare TRIB & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRIB
  • PCLA
  • Stock Information
  • Founded
  • TRIB 1992
  • PCLA 2008
  • Country
  • TRIB Ireland
  • PCLA Japan
  • Employees
  • TRIB N/A
  • PCLA N/A
  • Industry
  • TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PCLA Building Products
  • Sector
  • TRIB Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • TRIB Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • TRIB 18.3M
  • PCLA 18.6M
  • IPO Year
  • TRIB N/A
  • PCLA 2025
  • Fundamental
  • Price
  • TRIB $0.92
  • PCLA $0.31
  • Analyst Decision
  • TRIB
  • PCLA
  • Analyst Count
  • TRIB 0
  • PCLA 0
  • Target Price
  • TRIB N/A
  • PCLA N/A
  • AVG Volume (30 Days)
  • TRIB 86.7K
  • PCLA 150.8K
  • Earning Date
  • TRIB 11-14-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • TRIB N/A
  • PCLA N/A
  • EPS Growth
  • TRIB N/A
  • PCLA N/A
  • EPS
  • TRIB N/A
  • PCLA N/A
  • Revenue
  • TRIB $61,555,000.00
  • PCLA $5,065,197.00
  • Revenue This Year
  • TRIB $13.51
  • PCLA N/A
  • Revenue Next Year
  • TRIB $13.14
  • PCLA N/A
  • P/E Ratio
  • TRIB N/A
  • PCLA N/A
  • Revenue Growth
  • TRIB 8.31
  • PCLA 5.26
  • 52 Week Low
  • TRIB $0.48
  • PCLA $0.30
  • 52 Week High
  • TRIB $3.44
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • TRIB 38.25
  • PCLA 24.78
  • Support Level
  • TRIB $0.95
  • PCLA $0.30
  • Resistance Level
  • TRIB $1.04
  • PCLA $0.44
  • Average True Range (ATR)
  • TRIB 0.07
  • PCLA 0.03
  • MACD
  • TRIB 0.00
  • PCLA -0.01
  • Stochastic Oscillator
  • TRIB 27.93
  • PCLA 5.84

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: